Development and validation of an improved classification and risk stratification system for carotid body tumors: Multinational collaborative cohort study
Hisham Mehanna(University of Birmingham), Daniele Borsetto(University of Cambridge), Paweł Golusiński(Poznan University of Medical Sciences), Janet Dunn(National Health Service), Nilda Süslü(Psychiatric Association of Turkey), Peter Monksfield(Queen Elizabeth Hospital Birmingham), Nausica Montalto(University of Brescia), Pasquale Di Maio(University of Perugia), Pankaj Mistry(University of Warwick), Richard Irving(University of Birmingham), Paul Nankivell(University of Birmingham), Marco Zavatta(University of Padua), Alessandra Marcantoni(Ospedale Santa Chiara), Angela Ferrante, Neil Sharma(University of Birmingham), John Ayuk(University Hospitals Birmingham NHS Foundation Trust), Francesco Snider, Şefik Hoşal(Ankara University), Franco Grego(University of Padua), Francisco Valdés(Pontificia Universidad Católica de Chile), Oğuz Kuşçu(Hacettepe University), Kataryna Malec(1 Military Clinical Hospital with Outpatient Clinic), Mark Kay(University Hospitals Birmingham NHS Foundation Trust), Cesare Grandi(Ospedale Santa Chiara), Piero Nicolai(University of Padua)
Cited by 7
Related Papers
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
|The Lancet Oncology|2013|604
Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002—Medical Research Council Adult Leukaemia Working Party
|Journal of Clinical Oncology|2005|489
Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer
|European Journal of Cancer|2015|386